Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307341705> ?p ?o ?g. }
- W4307341705 endingPage "2569" @default.
- W4307341705 startingPage "2535" @default.
- W4307341705 abstract "The failure of anticancer chemotherapy is often due to the development of resistance to a variety of anticancer drugs. This phenomenon is called multidrug resistance (MDR) and is related to the overexpression of ABC transporters, such as P-glycoprotein, multidrug resistance- associated protein 1 and breast cancer resistance protein. Over the past few decades, several ABC protein modulators have been discovered and studied as a possible approach to evade MDR and increase the success of anticancer chemotherapy. Nevertheless, the co-administration of pump inhibitors with cytotoxic drugs, which are substrates of the transporters, does not appear to be associated with an improvement in the therapeutic efficacy of antitumor agents. However, more recently discovered MDR reversing agents, such as the two tetrahydroisoquinoline derivatives tariquidar and elacridar, are characterized by high affinity towards the ABC proteins and by reduced negative properties. Consequently, many analogs of these two derivatives have been synthesized, with the aim of optimizing their MDR reversal properties.This review aims to describe the MDR modulators carrying the tetraidroisoquinoline scaffold reported in the literature in the period 2009-2021, highlighting the structural characteristics that confer potency and/or selectivity towards the three ABC transport proteins.Many compounds have been synthesized in the last twelve years showing interesting properties, both in terms of potency and selectivity. Although clear structure-activity relationships can be drawn only by considering strictly related compounds, some of the compounds reviewed could be promising starting points for the design of new ABC protein inhibitors." @default.
- W4307341705 created "2022-10-31" @default.
- W4307341705 creator A5003820375 @default.
- W4307341705 creator A5005492881 @default.
- W4307341705 creator A5007182721 @default.
- W4307341705 creator A5031910544 @default.
- W4307341705 creator A5044635551 @default.
- W4307341705 date "2022-12-01" @default.
- W4307341705 modified "2023-10-14" @default.
- W4307341705 title "The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers" @default.
- W4307341705 cites W147439079 @default.
- W4307341705 cites W1525402398 @default.
- W4307341705 cites W1545285984 @default.
- W4307341705 cites W1546135534 @default.
- W4307341705 cites W1581236234 @default.
- W4307341705 cites W1607226074 @default.
- W4307341705 cites W1677499164 @default.
- W4307341705 cites W172657459 @default.
- W4307341705 cites W1768118903 @default.
- W4307341705 cites W1807250678 @default.
- W4307341705 cites W186995758 @default.
- W4307341705 cites W1918456921 @default.
- W4307341705 cites W1941252177 @default.
- W4307341705 cites W1966156572 @default.
- W4307341705 cites W1967331103 @default.
- W4307341705 cites W1968482535 @default.
- W4307341705 cites W1971072219 @default.
- W4307341705 cites W1971607633 @default.
- W4307341705 cites W1971866641 @default.
- W4307341705 cites W1975209977 @default.
- W4307341705 cites W1978994757 @default.
- W4307341705 cites W1979386452 @default.
- W4307341705 cites W1979715761 @default.
- W4307341705 cites W1981063012 @default.
- W4307341705 cites W1981140460 @default.
- W4307341705 cites W1982875074 @default.
- W4307341705 cites W1983518163 @default.
- W4307341705 cites W1983974579 @default.
- W4307341705 cites W1984619218 @default.
- W4307341705 cites W1985368942 @default.
- W4307341705 cites W1986634950 @default.
- W4307341705 cites W1988348505 @default.
- W4307341705 cites W1989064705 @default.
- W4307341705 cites W1989218878 @default.
- W4307341705 cites W1989335851 @default.
- W4307341705 cites W1990919886 @default.
- W4307341705 cites W1991019654 @default.
- W4307341705 cites W1993301860 @default.
- W4307341705 cites W1995020557 @default.
- W4307341705 cites W1999558499 @default.
- W4307341705 cites W2000512539 @default.
- W4307341705 cites W2000825690 @default.
- W4307341705 cites W2000941955 @default.
- W4307341705 cites W2001361864 @default.
- W4307341705 cites W2004122590 @default.
- W4307341705 cites W2005293447 @default.
- W4307341705 cites W2006228964 @default.
- W4307341705 cites W2008862048 @default.
- W4307341705 cites W2008935282 @default.
- W4307341705 cites W2009939473 @default.
- W4307341705 cites W2010081009 @default.
- W4307341705 cites W2012431429 @default.
- W4307341705 cites W2016894261 @default.
- W4307341705 cites W2020651374 @default.
- W4307341705 cites W2021399955 @default.
- W4307341705 cites W2023396498 @default.
- W4307341705 cites W2024250662 @default.
- W4307341705 cites W2024965589 @default.
- W4307341705 cites W2025672918 @default.
- W4307341705 cites W2025941747 @default.
- W4307341705 cites W2028533496 @default.
- W4307341705 cites W2031487956 @default.
- W4307341705 cites W2032167680 @default.
- W4307341705 cites W2033201435 @default.
- W4307341705 cites W2033346155 @default.
- W4307341705 cites W2033767311 @default.
- W4307341705 cites W2037136836 @default.
- W4307341705 cites W2038201387 @default.
- W4307341705 cites W2042890253 @default.
- W4307341705 cites W2043433022 @default.
- W4307341705 cites W2044053408 @default.
- W4307341705 cites W2044154925 @default.
- W4307341705 cites W2046639188 @default.
- W4307341705 cites W2048213764 @default.
- W4307341705 cites W2052983303 @default.
- W4307341705 cites W2054340359 @default.
- W4307341705 cites W2054490397 @default.
- W4307341705 cites W2054737607 @default.
- W4307341705 cites W2055433647 @default.
- W4307341705 cites W2055904567 @default.
- W4307341705 cites W2059152998 @default.
- W4307341705 cites W2059880023 @default.
- W4307341705 cites W2064865731 @default.
- W4307341705 cites W2067391745 @default.
- W4307341705 cites W2067849966 @default.
- W4307341705 cites W2069382823 @default.
- W4307341705 cites W2070083618 @default.
- W4307341705 cites W2070691527 @default.